Document Detail

Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction.
MedLine Citation:
PMID:  20956486     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Small studies suggest that postconditioning reperfusion interrupted by brief repetitive cycles of reocclusions, may protect the myocardium in the clinical setting. OBJECTIVE: To test the hypothesis that postconditioning limits infarct size in relation to the area at risk in patients with ST elevation myocardial infarction (STEMI). METHODS: 76 patients (aged 37-87 years) eligible for primary percutaneous coronary intervention due to STEMI were randomised to standard percutaneous coronary intervention (n = 38) or postconditioning, consisting of four cycles of 60 s reperfusion and 60 s of reocclusion before permanent reperfusion (n = 38). RESULTS: The area at risk was determined from angiographic abnormally contracting segments. Infarct size was quantified from delayed enhancement MRI on days 6-9. Infarct size, expressed in relation to the area at risk, did not differ between the control group (44%; 30, 56) (median and quartiles) and the post-conditioned group (47%; 23, 63). The slope of the regression lines relating infarct size to the area at risk differed between the two groups. Infarct size was significantly (p = 0.001) reduced by postconditioning in patients with large areas at risk. The area under the curve and peak troponin T release and CKMB during 48 h did not differ between patients in the control and postconditioning groups. CONCLUSIONS: This prospective, randomised trial suggests that postconditioning does not reduce infarct size in patients with STEMI in the overall study group. The data indicate that postconditioning may be of value in patients with large areas at risk. Clinical trial registration information Karolinska Clinical Trial Registration ( Unique identifier: CT20080014.
Peder Sörensson; Nawzad Saleh; Frederic Bouvier; Felix Böhm; Magnus Settergren; Kenneth Caidahl; Per Tornvall; Håkan Arheden; Lars Rydén; John Pernow
Related Documents :
20508796 - Propofol has delayed myocardial protective effects after a regional ischemia/reperfusio...
1446316 - Pretreatment with buflomedil enhances ventricular function by reducing the dysfunctiona...
3112436 - Altered lipoxygenase metabolites and leukocyte involvement in an acute occlusion-reperf...
20450906 - Cardioprotective effects of 44bu, a newly synthesized compound, in rat heart subjected ...
24817146 - Exploration of pharmacological interventions to prevent isoproterenol-induced myocardia...
10694526 - Permanent, direct his-bundle pacing: a novel approach to cardiac pacing in patients wit...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Heart (British Cardiac Society)     Volume:  96     ISSN:  1468-201X     ISO Abbreviation:  Heart     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-19     Completed Date:  2010-11-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602087     Medline TA:  Heart     Country:  England    
Other Details:
Languages:  eng     Pagination:  1710-5     Citation Subset:  AIM; IM    
Karolinska University Hospital, 171 76 Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects,  methods*
Biological Markers / blood
Creatine Kinase, MB Form / blood
Electrocardiogram Pattern
Ischemic Preconditioning, Myocardial / methods*
Magnetic Resonance Imaging / methods
Middle Aged
Myocardial Infarction / pathology,  physiopathology,  therapy*
Myocardial Reperfusion Injury / etiology,  prevention & control*
Prospective Studies
Stroke Volume
Troponin T / blood
Reg. No./Substance:
0/Biological Markers; 0/Troponin T; EC Kinase, MB Form

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the pres...
Next Document:  Increased expression and plasma levels of myeloperoxidase are closely related to the presence of ang...